Skip to main content
Skip to content
Case File
efta-efta01521295DOJ Data Set 10Correspondence

EFTA Document EFTA01521295

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521295
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT For the Period 7/1/12 to 7/31/12 Equity Summary Asset Categories Beginning Market Value Ending Market Value Change In Value Current Allocation Asset Categories US Large Cap Equity 55.277.08 54.327.28 (949.80) 1% US Small/Mk! Cap Equity 5,130.00 5,160.00 30.00 1% Non-US Equity 142.05 138.50 (3.55) 1% Preferred Stocks 441,281.00 444,730.00 3,469.00 5% Preferred Stocks Concentrated 8 Other Equity 197.643.50 198494.00 850.50 2% N*?US Equity Total Value $699,453.63 5702,849.78 $3,396.15 10% Market Value/Cost Current Period Value Market Value Tax Cost Unrealized Gain/Loss Estimated Annual Income Accrued Dividends Yield Equity Detail 702,849.78 784,967.39 (62.117.61) 45,693.48 4,849.00 6.48% US Small Mid Cap Spurt), US Large Cap Equity Equity as a percentage of your portfolio - 10 % Concentrated 6 Other Equity Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA 86.12 95.000 8,181.40 11,403.30 (3,221.90) 64.60 0.79% 16.15 JP Morgan Page 4 of 31 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048669 SDNY_GM_00317867 EFTA01521295

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.